Descrizione del progetto
Prepararsi a soddisfare le necessità urgenti della prossima pandemia
La pandemia da COVID-19 ha rivelato una risposta carente all’elevata domanda di prodotti e servizi medici. Ciò ha richiesto un nuovo approccio per soddisfare i picchi di domanda nel corso delle crisi sanitarie. Il progetto RESERVIST, finanziato dall’UE, affronterà questo problema realizzando una rete principale di centri di manifattura e distribuzione per soddisfare le richieste urgenti di fornitura nell’arco di 48 ore. Per farlo metterà in collegamento le aziende necessarie, ottimizzerà produzione e distribuzione, collaborando nel contempo con la comunità globale dei maker per soddisfare la crescente domanda. L’obiettivo è quello di avvalersi delle innovazioni più recenti e aumentare la flessibilità di produzione, garantendo la consegna tempestiva di forniture e servizi per la prossima crisi sanitaria.
Obiettivo
RESERVIST aims to establish ‘reservist cells’ that in times of crises can be activated within 48hrs to switch to manufacturing medical products and services that are spiking in demand. Such a ‘reservist cell’ will consist of (i) a backbone network of core companies for manufacturing and testing; (ii) an extended network for further capacities (eg local provision, packaging, distribution, customization,…); (iii) a digital coordination platform and (iv) a pool of experts from the companies of the network. These cells will become operational in case of an emergency/pandemic but to make economic sense, the same approach of rapid flexibility and adaptability will be used to deal with surging demand in ‘normal circumstances’.
To realise this concept, we will first work on three levels individually: network level, connected manufacturing/digital manufacturing level and technical level, the latter referring to tweaking manufacturing lines, developing required materials and establishing links with testing/certification. Next, we will demonstrate the repurposing of 5 existing manufacturing lines within 48hrs towards manufacturing of ‘textile PPE’ (surgical and respiratory face masks, medical aprons) and ‘respiratory ventilators’ (invasive and non invasive) that comply with necessary testing and certification and proceed with the embedment of the reservist cells at the partners in the network. We will develop blueprints for further take-up and replication of the concept to other sectors. Within the project we will develop two replication demos: ‘disinfection equipment’ and ‘emergency medical equipement’. To support the Cells we will tap into the worldwide maker community and into relevant OITBs and networks.
The consortium is strongly industry-driven, including 4 LE and 7 SMEs coming from 7 EU countries. To maximise impact, we will extend our partner network and our Impact Support Group (18 Support Letters provided at proposal stage).
Campo scientifico
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health sciencesclinical medicineemergency medicine
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- engineering and technologymaterials engineeringtextiles
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationstelecommunications networksdata networks
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
H2020-SC1-PHE-CORONAVIRUS-2020-2
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-PHE-CORONAVIRUS-2020-2-NMBP
Meccanismo di finanziamento
IA - Innovation actionCoordinatore
1070 BRUXELLES
Belgio
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.